Sort
82,697 grants matching “vaccine development”
Structural Studies of Pattern Recognition Receptors
$1,151,487Tsan Xiao · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,150,820Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
VACCINATION AGAINST INTRAPARTUM HIV CLADE C TRANSMISSION
$1,150,724Ruth Margrit Ruprecht · Dana-Farber Cancer Inst · P01 · FY2006 · AI
Dimandelic Acid Ethers As Topical Microbicides For HIV
$1,150,477Mount Sinai School Of Medicine Of Nyu · P01 · FY2001 · HD
Advancement to Clinical Candidate of Novel, Potent and Selective Chikungunya virus inhibitor series
$1,150,441Daniel C Pevear · Venatorx Pharmaceuticals, Inc. · R44 · FY2017 · AI
An Avirulent Arthroconidial Vaccine Candidate to Prevent Human Coccidioidomycosis
$1,150,297John N Galgiani · University Of Arizona · R01 · FY2018 · AI
BSL3 Practices Core
$1,150,205Jay Rappaport · Tulane University Of Louisiana · UC7 · FY2025 · AI
MU-JHU HPTU TRIAL SITE - UGANDA
$1,150,082Johns Hopkins University · U01 · FY2003 · AI
An Avirulent Arthroconidial Vaccine Candidate to Prevent Human Coccidioidomycosis
$1,149,998John N Galgiani · University Of Arizona · R01 · FY2020 · AI
Predicting immune responses that correlate with protection against tuberculosis
$1,149,943Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · HL
Development And Production Of A Multiclade HIV-1 DNA Plasmid Vaccine
$1,149,913Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2011 · AI
Development Of A Multicomponent HIV-1 Recombinant Adenoviral Vector Vaccine
$1,149,913Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2011 · AI
Development of an Ad5 [E1-, E2b-] HIV-1 vaccine for use in Ad5 Immunized Vaccinee
$1,149,641Frank R. Jones · Etubics Corporation · R44 · FY2010 · AI
Viral Pathogenesis and Therapeutics
$1,149,418Adolfo Garcia-Sastre · Wadsworth Center · U54 · FY2008 · AI
Immunotherapeutics Against Arenaviruses
$1,149,274Robert F Garry · Scripps Research Institute, The · U19 · FY2018 · AI
Production of Pedigreed SPF Rhesus Macaques
$1,149,256Jeffrey A Roberts · University Of California At Davis · U42 · FY2014 · OD
Project 2: Molecular Signatures of West Nile virus susceptibility
$1,149,216Ruth R Montgomery · Yale University · U19 · FY2021 · AI
NORTHERN CALIFORNIA PEDIATRIC AIDS TREATMENT CENTER
$1,149,037University Of California San Francisco · U01 · FY2001 · AI
Task V28: Process Development and Master Bank Production for a Staph aureus Vaccine Candidate
$1,149,011Andreas Neubert · Idt Biologika Gmbh · N01 · FY2021 · AI
The Impact of HIV Infection on Immunologic, Transcriptomic, and Metabolomic Signatures of Medication-Assisted Therapy for Opioid Addiction
$1,148,831Sandra Ann Springer · Yale University · R01 · FY2020 · DA
The Impact of HIV Infection on Immunologic, Transcriptomic, and Metabolomic Signatures of Medication-Assisted Therapy for Opioid Addiction
$1,148,831Sandra Ann Springer · Yale University · R01 · FY2017 · DA
The Impact of HIV Infection on Immunologic, Transcriptomic, and Metabolomic Signatures of Medication-Assisted Therapy for Opioid Addiction
$1,148,831Sandra Ann Springer · Yale University · R01 · FY2019 · DA
Antibody immunotherapeutics for biodefense against Lassa virus
$1,148,492Robert F Garry · Tulane University Of Louisiana · R01 · FY2017 · AI
The humoral response to Zika virus infection and vaccination
$1,148,245Theodore Pierson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
An Avirulent Arthroconidial Vaccine Candidate to Prevent Human Coccidioidomycosis
$1,148,120John N Galgiani · University Of Arizona · R01 · FY2019 · AI